Edesa Biotech, Inc. - Common Shares (NQ:EDSA)
Press Releases about Edesa Biotech, Inc. - Common Shares
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
February 09, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Edesa Biotech Reports Fiscal Year 2023 Results
December 15, 2023
Via ACCESSWIRE
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
November 20, 2023
Via ACCESSWIRE
Edesa Biotech to Present at Dermatology Drug Development Summit
October 26, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Edesa Biotech Announces One-for-Seven Reverse Share Split
October 10, 2023
Via ACCESSWIRE
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
September 28, 2023
Via ACCESSWIRE
Edesa Biotech Reports Fiscal Third Quarter 2023 Results
August 09, 2023
Via ACCESSWIRE
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
June 27, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Edesa Biotech to Participate in Swiss Biotech Day
April 20, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
February 10, 2023
Via ACCESSWIRE
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
February 01, 2023
Via ACCESSWIRE
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
January 17, 2023
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>